The FDA has approved tirzepatide for reduction of cardiovascular risk in adults with type 2 diabetes, Eli Lilly announced.
Pseudophakic patients with glaucoma who aren’t doing well on their drops or who are progressing despite reasonable adherence ...
The United States’ death rate likely dropped to a record low last year, according to provisional CDC data.The National Center ...
In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without ...
In patients with symptomatic nonobstructive hypertrophic cardiomyopathy, aficamten led to greater improvements in health ...
In patients with atrial fibrillation and intermediate risk for stroke, direct oral anticoagulants were linked to reduced risk ...
The FDA has approved Bixlenvo, the first single-pill daily HIV therapy for adults being successfully treated on more complex ...
E-scooters are popular for recreation and transportation, with ride-share options available in 133 cities across the United ...
The FDA has approved tirzepatide for reduction of cardiovascular risk in adults with type 2 diabetes, Eli Lilly ...
From 2013 to 2022, the rate of asthma-related hospitalizations that led to ICU admission did not change in adults but rose in ...
The FDA has approved Lisraya for the treatment of dermatomyositis in adults, the agency announced in a press release. The ...
Researchers identified quantifiable amounts of lead in popular tampon brands but determined such levels have “no demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results